SCHEMBL21098321

SCHEMBL21098321

CC1(SNC(=O)c2ccc3nc(Cl)sc3c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.44
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
CHRNA7 P36544 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KMT2A Q03164 3/20 0.40
LRRK2 Q5S007 2/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40
PTPN11 Q06124 1/20 0.40
MEN1 O00255 2/20 0.39
MMP13 P45452 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1748004 0.79 SMN1; SMN2 (0.63) LCKNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL20049226 0.79 LMNA (0.46) LCKNPC1RAB9ASMN1; SMN2HSD17B10
SCHEMBL20043370 0.78 KMT2A (0.43) LCKNPC1RAB9ASMN1; SMN2CHRNA7
SCHEMBL1033009 0.74 LMNA (0.64) LCKNPC1RAB9ACHRNA7HSD17B10
SCHEMBL2000313 0.73 NPC1 (0.51) NPC1RAB9ASMN1; SMN2KMT2ALRRK2
SCHEMBL1983363 0.72 PIK3CA (0.64) NPC1RAB9ASMN1; SMN2HSD17B10KMT2A
SCHEMBL1095256 0.72 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2HSD17B10KMT2A
SCHEMBL1036069 0.72 KDM4E (0.62) NPC1RAB9ASMN1; SMN2HSD17B10KMT2A
SCHEMBL1748094 0.71 POLB (0.55) RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL9305825 0.71 NPC1 (0.72) LCKNPC1RAB9ASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019118571-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2019-06-20 WO disclosed